These results are consistent with reports of decreased tumor cell proliferative capability in breast cancer, prostate cancer, lung cancer, and squamous cell carcinoma after TCTP down-regulation [24,38,39,40]. This evidence concerns the gene TPT1 and squamous cell carcinoma.